REL	Cancer
ORG	Research
ORG	Campaign
EPS	signed
DIS	a
CON	deal
REL	with
DIS	a
ORG	US
CON	pharmaceuticals
CON	company
SUB	to
EXS	develop
DIS	a
IST	pioneering
CON	cancer
CON	treatment
NIL	.
